Clinical Trials in Canada
The innovative pharmaceutical industry has sponsored over two-thirds of clinical trials initiated in Canada in the last 5 years and contributed over $15 billion to the Canadian economy annually….
All resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
Research Note: Oncology Clinical Trials: Canada Within the International Context
Clinical trials provide Canadian oncology patients with earlier access to new, innovative cancer treatments. But changes pending to the PMPRB will make the Canadian pharmaceutical market less attractive for investment….
The Value of the Innovative Pharmaceutical Industry – A Report Summary
This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts of patient support programs and clinical trials as well as…
Clinical Trials Research Note
In many areas of high unmet patient need, early access to new medicines through clinical trials are the only option for Canadian patients. There are over 3,000 ongoing clinical trials…
